v3.26.3
Earnings or Loss Per Share - Potential Diluted Effect of Diluted Loss Per Share (Details)
shares in Millions
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2026
$ / shares
shares
Sep. 30, 2026
shares
Sep. 30, 2025
shares
Sep. 30, 2026
shares
Sep. 30, 2025
shares
Outstanding options, SARs and RSUs          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares)   60.4 38.6 60.4 45.0
Outstanding options, SARs and RSUs | LILA Awards          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares) 17.4        
Conversion ratio 1.43        
Weighted average exercise price (in dollars per share) | $ / shares $ 6.98        
Outstanding options, SARs and RSUs | LILAK Awards          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares) 35.7        
Weighted average exercise price (in dollars per share) | $ / shares $ 6.81        
Outstanding PSUs and PSARs          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares)   11.8 8.5 11.8 8.6
Outstanding PSUs and PSARs | LILA Awards          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares) 3.9        
Weighted average exercise price (in dollars per share) | $ / shares $ 9.70        
Outstanding PSUs and PSARs | LILAK Awards          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares) 7.9        
Conversion ratio 1.47        
Weighted average exercise price (in dollars per share) | $ / shares $ 9.50        
LTVP and ESPP          
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]          
Securities excluded (in shares)   6.0 5.8 6.0 5.8